Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

Early-career scientists from New York University, Stanford University and Rensselaer Polytechnic Institute were recognized for their ambitious "dream project" proposals

TARRYTOWN, N.Y., July 31, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the recipients of the 2026 Regeneron Prize for Creative Innovation (“the Regeneron Prize”). This annual award celebrates outstanding early-career scientists, nominated by their research universities, whose creativity and innovation set new standards in biomedical research. Winners are chosen by a panel of Regeneron scientists based on the scientific merit, originality and creativity of 'dream project' proposals.